MedPath

Oestrogen Withdrawal in Hypopituitary Women

Not Applicable
Completed
Conditions
Hypopituitarism
Interventions
Drug: oestrogen
Registration Number
NCT00572390
Lead Sponsor
University of Aarhus
Brief Summary

By exploring hormonal status in hypopituitary women during oestrogen treatment and without estrogen substitution the influence on sexhormones and organ function is estimated.

Detailed Description

38 hypopituitary women were examinined twice. During oestrogen treatment and after 1 month estrogen withdrawal. A control group of healthy women were examined once.Antropometric data and hormonal parameters were collected.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
38
Inclusion Criteria
  • Hypopituitarism
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
2oestrogenOestrogen treatment
1oestrogenNo oestrogen treatment
Primary Outcome Measures
NameTimeMethod
androgens, IGF-I, body composition, liver enzymes,1 month
Secondary Outcome Measures
NameTimeMethod
Grehlin, adiponection, leptin1 month

Trial Locations

Locations (1)

Århus Universityhospital

🇩🇰

Århus, Denmark

© Copyright 2025. All Rights Reserved by MedPath